Results 181 to 190 of about 30,656 (238)

Pancreatic neuroendocrine microtumors in the elderly: A retrospective study using cadaveric pancreatic tissue. [PDF]

World J Gastrointest Oncol
Yang T, Ren K, Chen XQ, Toriumi T, Natsuyama Y, Li J, Sukeda A, Nagao T, Yi SQ.   +8 more
europepmc   +1 more source

A Rare Case of Asymptomatic Insulinoma with Mesocolonic Lymph Node Metastases and Long-Term Stability. [PDF]

Surg Case Rep
Kitami C, Kawachi Y, Nishimura A, Nakano T, Makino S, Kawahara M.   +5 more
europepmc   +1 more source

Ovarian carcinoid tumor with carcinoid heart syndrome: A case report and literature review. [PDF]

Gynecol Oncol Rep
Jang M, Mulugeta-Gordon L, Carver J, Tupper N, Barbera J, Schwartz L, Latif N.   +6 more
europepmc   +1 more source

Intrathyroidal thymic carcinoma comprising squamous cell and small cell carcinoma components: A case report. [PDF]

World J Clin Oncol
Shan BW, Yu JH, Ren T.
europepmc   +1 more source

Responses to medical treatment in patients with metastatic unresectable small intestinal neuroendocrine tumors - A single center study of 378 patients. [PDF]

J Neuroendocrinol
Slott C, Langer SW, Oturai P, Møller S, Hansen CP, Kjaer A, Holmager P, Klose M, Garbyal RS, Knigge U, Andreassen M.   +10 more
europepmc   +1 more source

Pure large-cell neuroendocrine carcinoma of the bladder with pelvic organ invasion: A case report. [PDF]

Urol Case Rep
Chebbi S, Alouane HBH, Oueslati MA, Hedhli R, Ben Brahim E, Ben Rhouma S.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma

European Journal of Endocrinology, 1997
Abstract Specific assays for measurements of circulating chromogranin (Cg) A, CgB, CgC and pancreastatin (Ps) have recently been developed. The aim of the present study was to investigate the usefulness of these markers in diagnosing and following the effects of treatment of patients with phaeochromocytoma, and to compare the results with those
M, Stridsberg, E S, Husebye
openaire   +2 more sources

Chromogranin A and Chromogranin B in Noninvasive and Invasive Breast Carcinoma

Endocrine Pathology, 2002
Recent progress in the study of chromogranins has revealed that there are many novel peptides derived from chromogranin with their multiple pathophysiologic roles. To learn the possible roles of chromogranin in breast carcinoma, we immunohistochemically investigated tissue localization of chromogranin A (CgA) and chromogranin B (CgB) in 10 normal ...
Noriko, Kimura, Ryuichi, Yoshida, Shin-ichiro, Shiraishi, Monika, Pilichowska, Noriaki, Ohuchi   +4 more
openaire   +2 more sources

Measurements of chromogranin B can serve as a complement to chromogranin A

Regulatory Peptides, 2007
CgA has been shown to be an excellent marker for neuroendocrine tumours. However, there are two major drawbacks with CgA measurements; elevated levels are common in patients with decreased renal function and in patients on treatment with proton pump inhibitors. These problems are not seen with CgB measurements.
Mats, Stridsberg, Barbro, Eriksson, Bengt, Fellström, Gudjon, Kristiansson, Eva, Tiensuu Janson   +4 more
openaire   +2 more sources